Rilmazolam

Rilmazolam
Clinical data
Trade names	(none, active metabolite of Rilmazafone)
Legal status
Legal status	Generally Legal;
Identifiers
	IUPAC name 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-[1,2,4]triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide;
CAS Number	50330-59-1 ;
PubChem CID	148494;
UNII	242T8WV28A;
CompTox Dashboard (EPA)	DTXSID50198345;
Chemical and physical data
3D model (JSmol)	Interactive image;
	SMILES CN(C)C(=O)C1=NN2C(=N1)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4Cl;
	InChI InChI=InChI=1S/C19H15Cl2N5O/c1-25(2)19(27)18-23-16-10-22-17(12-5-3-4-6-14(12)21)13-9-11(20)7-8-15(13)26(16)24-18/h3-9H,10H2,1-2H3; Key:YMJXPUGNWIWFJI-UHFFFAOYSA-N;

Rilmazolam, is a benzodiazepine derivative which acts as a sedative and hypnotic drug, and the active metabolite of the drug Rilmazafone.^[1] It has never been developed for medical uses, yet the aforementioned prodrug is an approved medication in Japan.

^ Koike M, Norikura R, Sugeno K (March 1986). "Intestinal activation of a new sleep inducer 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, in rats". Journal of Pharmacobio-Dynamics. 9 (3): 315–20. doi:10.1248/bpb1978.9.315. PMID 3454653.

[pmid3454653-1] Koike M, Norikura R, Sugeno K (March 1986). "Intestinal activation of a new sleep inducer 450191-S, a 1H-1,2,4-triazolyl benzophenone derivative, in rats". Journal of Pharmacobio-Dynamics. 9 (3): 315–20. doi:10.1248/bpb1978.9.315. PMID 3454653.

[1]